Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.3000
-0.0500 (-14.29%)
Jul 27, 2026, 12:30 PM GMT
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 8.01 million as of July 27, 2026. Its market cap has increased by 450.12% in one year.
Market Cap
8.01M
Enterprise Value
5.67M
Revenue
2.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.30
ChartMarket Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 8.01M, a decrease of -84.53%. That is a compound annual growth rate of -27.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 8.01M | -27.04% |
| Dec 31, 2025 | 10.97M | 16.74% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.51B |
| GSK plc | 76.44B |
| Haleon | 32.02B |
| Smith & Nephew | 9.59B |
| Renalytix | 11.58M |
| Genflow Biosciences | 10.76M |
| Cizzle Biotechnology Holdings | 8.71M |
| Proteome Sciences | 6.31M |